These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 12482756)

  • 61. Quantifying the Binding Interaction between the Hypoxia-Inducible Transcription Factor and the von Hippel-Lindau Suppressor.
    Domene C; Jorgensen C; Vanommeslaeghe K; Schofield CJ; MacKerell A
    J Chem Theory Comput; 2015 Aug; 11(8):3946-54. PubMed ID: 26574473
    [TBL] [Abstract][Full Text] [Related]  

  • 62. HIFalpha targeted for VHL-mediated destruction by proline hydroxylation: implications for O2 sensing.
    Ivan M; Kondo K; Yang H; Kim W; Valiando J; Ohh M; Salic A; Asara JM; Lane WS; Kaelin WG
    Science; 2001 Apr; 292(5516):464-8. PubMed ID: 11292862
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Role of iron (II)-2-oxoglutarate-dependent dioxygenases in the generation of hypoxia-induced phosphatidic acid through HIF-1/2 and von Hippel-Lindau-independent mechanisms.
    Martín-Puig S; Temes E; Olmos G; Jones DR; Aragonés J; Landázuri MO
    J Biol Chem; 2004 Mar; 279(10):9504-11. PubMed ID: 14681229
    [TBL] [Abstract][Full Text] [Related]  

  • 64. HIF prolyl and asparaginyl hydroxylases in the biological response to intracellular O(2) levels.
    Masson N; Ratcliffe PJ
    J Cell Sci; 2003 Aug; 116(Pt 15):3041-9. PubMed ID: 12829734
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Differences in hydroxylation and binding of Notch and HIF-1alpha demonstrate substrate selectivity for factor inhibiting HIF-1 (FIH-1).
    Wilkins SE; Hyvärinen J; Chicher J; Gorman JJ; Peet DJ; Bilton RL; Koivunen P
    Int J Biochem Cell Biol; 2009 Jul; 41(7):1563-71. PubMed ID: 19401150
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Biochemical purification and pharmacological inhibition of a mammalian prolyl hydroxylase acting on hypoxia-inducible factor.
    Ivan M; Haberberger T; Gervasi DC; Michelson KS; Günzler V; Kondo K; Yang H; Sorokina I; Conaway RC; Conaway JW; Kaelin WG
    Proc Natl Acad Sci U S A; 2002 Oct; 99(21):13459-64. PubMed ID: 12351678
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Hypoxia-dependent sequestration of an oxygen sensor by a widespread structural motif can shape the hypoxic response--a predictive kinetic model.
    Schmierer B; Novák B; Schofield CJ
    BMC Syst Biol; 2010 Oct; 4():139. PubMed ID: 20955552
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Siah-1 facilitates ubiquitination and degradation of factor inhibiting HIF-1alpha (FIH).
    Fukuba H; Yamashita H; Nagano Y; Jin HG; Hiji M; Ohtsuki T; Takahashi T; Kohriyama T; Matsumoto M
    Biochem Biophys Res Commun; 2007 Feb; 353(2):324-9. PubMed ID: 17188242
    [TBL] [Abstract][Full Text] [Related]  

  • 69. HIF hydroxylation and cellular oxygen sensing.
    Metzen E; Ratcliffe PJ
    Biol Chem; 2004; 385(3-4):223-30. PubMed ID: 15134335
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Role of the C-terminal alpha-helical domain of the von Hippel-Lindau protein in its E3 ubiquitin ligase activity.
    Lewis MD; Roberts BJ
    Oncogene; 2004 Mar; 23(13):2315-23. PubMed ID: 14691445
    [TBL] [Abstract][Full Text] [Related]  

  • 71. HIF-1alpha and EPAS ubiquitination mediated by the VHL tumour suppressor involves flexibility in the ubiquitination mechanism, similar to other RING E3 ligases.
    Paltoglou S; Roberts BJ
    Oncogene; 2007 Jan; 26(4):604-9. PubMed ID: 16862177
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Quantitative mass spectrometry reveals dynamics of factor-inhibiting hypoxia-inducible factor-catalyzed hydroxylation.
    Singleton RS; Trudgian DC; Fischer R; Kessler BM; Ratcliffe PJ; Cockman ME
    J Biol Chem; 2011 Sep; 286(39):33784-94. PubMed ID: 21808058
    [TBL] [Abstract][Full Text] [Related]  

  • 73. The conservation and functionality of the oxygen-sensing enzyme Factor Inhibiting HIF (FIH) in non-vertebrates.
    Hampton-Smith RJ; Davenport BA; Nagarajan Y; Peet DJ
    PLoS One; 2019; 14(4):e0216134. PubMed ID: 31034531
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Hypoxia-inducible factor 1 proteomics and diving adaptations in ringed seal.
    Johnson P; Elsner R; Zenteno-Savín T
    Free Radic Biol Med; 2005 Jul; 39(2):205-12. PubMed ID: 15964512
    [TBL] [Abstract][Full Text] [Related]  

  • 75. HIF hydroxylation and the mammalian oxygen-sensing pathway.
    Safran M; Kaelin WG
    J Clin Invest; 2003 Mar; 111(6):779-83. PubMed ID: 12639980
    [No Abstract]   [Full Text] [Related]  

  • 76. Coordinate regulation of the oxygen-dependent degradation domains of hypoxia-inducible factor 1 alpha.
    Chan DA; Sutphin PD; Yen SE; Giaccia AJ
    Mol Cell Biol; 2005 Aug; 25(15):6415-26. PubMed ID: 16024780
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Selective inhibition of factor inhibiting hypoxia-inducible factor.
    McDonough MA; McNeill LA; Tilliet M; Papamicaël CA; Chen QY; Banerji B; Hewitson KS; Schofield CJ
    J Am Chem Soc; 2005 Jun; 127(21):7680-1. PubMed ID: 15913349
    [TBL] [Abstract][Full Text] [Related]  

  • 78. The von Hippel-Lindau protein, HIF hydroxylation, and oxygen sensing.
    Kaelin WG
    Biochem Biophys Res Commun; 2005 Dec; 338(1):627-38. PubMed ID: 16153592
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Inhibitor of nuclear factor-kappaB alpha derepresses hypoxia-inducible factor-1 during moderate hypoxia by sequestering factor inhibiting hypoxia-inducible factor from hypoxia-inducible factor 1alpha.
    Shin DH; Li SH; Yang SW; Lee BL; Lee MK; Park JW
    FEBS J; 2009 Jul; 276(13):3470-80. PubMed ID: 19456861
    [TBL] [Abstract][Full Text] [Related]  

  • 80. von Hippel-Lindau tumor suppressor: not only HIF's executioner.
    Czyzyk-Krzeska MF; Meller J
    Trends Mol Med; 2004 Apr; 10(4):146-9. PubMed ID: 15162797
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.